Volume 7, Issue 25 (1-2017)                   NCMBJ 2017, 7(25): 127-134 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabatabaei Panah A S, Akbarzadeh R. Expression of CD-34, OCT-4 and Brachyury genes of cardiomyocytes derived from human embryonic stem cells. NCMBJ 2017; 7 (25) :127-134
URL: http://ncmbjpiau.ir/article-1-927-en.html
Department of Biology, Islamic Azad University, East Tehran Branch, Tehran, Iran , tabatabaeipanah@gmail.com
Abstract:   (5344 Views)
Aim and Background: Cardiomyocytes derived from human embryonic stem cells (hESCs) could be useful in restoring heart function after myocardial infarction or in heart failure. The hESCs can differentiate in vitro into spontaneously contracting cardiomyocytes and produce a model to investigate the early developmental stages of this system. After removing of cells from their feeder layer, hESCs create embryoid bodies (EB). Plating of EB result in developing areas of beating cells. Materials and Methods: After stem cell culture, cardiomyocyte’s mRNA extracted in different time after differentiation. The expression pattern CD-34, OCT-4 and Brachyury were analyzed by reverse transcriptase-polymerase chain reaction (RT-PCR). Results: There was an enhanced expression of as CD-34 from day 21 in EB in suspension. The OCT-4 gene expression was in 5-day-old EB and Brachyury expression was significantly increased by day 21. Conclusion: hESCs might be useful as an effective model system for understanding the developmental processes and functioning of the human heart.
Full-Text [PDF 366 kb]   (1598 Downloads)    
Type of Study: Research Article | Subject: Cellular and molecular
Received: 2017/04/19 | Accepted: 2017/04/19 | Published: 2017/04/19

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | New Cellular and Molecular Biotechnology Journal

Designed & Developed by : Yektaweb